# FDA 483 - BioMarin Pharmaceuticals, Inc. - December 13, 2024

Source: https://www.keypedia.com/records/483/biomarin-pharmaceuticals-inc/4956b215-c9fb-4827-95d5-930cd2e1c7f1

> FDA 483 for BioMarin Pharmaceuticals, Inc. on December 13, 2024. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: BioMarin Pharmaceuticals, Inc.
- Inspection Date: 2024-12-13
- Product Type: other
- Office Name: Office of the Commissioner
- Summary: I am unable to provide a summary of the FDA 483 document as the content extraction failed. The provided input indicates an error stating: "All PDF extraction methods failed for file: /tmp/extractor_el59ulwu.pdf. Last OCR error: Tesseract process timeout." Without the document's content, I cannot identify the company name, inspection dates, main violations or issues, the relevant regulatory framework, or any required actions.

## Related Documents

- [483 - 2013-09-24](https://www.keypedia.com/records/483/biomarin-pharmaceuticals-inc/c6225f0a-c847-4175-aca8-8e0609be02a9)

## Related Officers

- [FDA_PERSONNEL](https://www.keypedia.com/people/extraction-failed/f8d11a9b-3d86-47a8-a6cb-2c939dae9ea6)

Company: https://www.keypedia.com/companies/biomarin-pharmaceuticals-inc/f98a7765-c14f-48fa-a466-329cf0e50f3d

Office: https://www.keypedia.com/offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424